Chargement en cours...
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
Pancreatic cancer remains one of the most lethal malignant diseases worldwide. The majority of patients present with advanced disease and, therefore, need palliative chemotherapy. Some chemotherapeutic regimens have been well established as first-line therapies and have been shown to increase surviv...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6084072/ https://ncbi.nlm.nih.gov/pubmed/30122951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S166405 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|